2008
DOI: 10.1016/s0001-4079(19)32685-8
|View full text |Cite
|
Sign up to set email alerts
|

Centre d’information et de dépistage de la drépanocytose à Paris

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
0
0
Order By: Relevance
“…The country-scale benefit of newborn screening is likely to be confirmed in coming years, and clinical protocols for the comprehensive care of all affected newborns in the various countries are likely to be shared. In parallel, genetic counseling and prenatal diagnosis for SCD carriers might help to raise awareness of the potential consequences of carrying abnormal Hb traits, assess the risk of recurrence, and promote family testing (59,93,102).…”
Section: Clinical Characteristics and Social Impact Of Sickle Cell Di...mentioning
confidence: 99%
“…The country-scale benefit of newborn screening is likely to be confirmed in coming years, and clinical protocols for the comprehensive care of all affected newborns in the various countries are likely to be shared. In parallel, genetic counseling and prenatal diagnosis for SCD carriers might help to raise awareness of the potential consequences of carrying abnormal Hb traits, assess the risk of recurrence, and promote family testing (59,93,102).…”
Section: Clinical Characteristics and Social Impact Of Sickle Cell Di...mentioning
confidence: 99%